Cubicin (Royalty rights) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Cubicin (Royalty rights) General Information
Description
A portfolio of royalty interests in an antibiotic drug. The portfolio comprises royalty rights in Cubicin, an antibiotic in a class of anti-infectives called lipopeptides.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Buildings and Property
Other Industries
Other Business Products and Services
Acquirer
Primary Office
- United States
Cubicin (Royalty rights) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|